drugset / Trial / NCT06938763
Evaluation of the Safety, Tolerability, and Pharmacokinetics of J4 in Healthy Adults
RandomizedSequentialDouble-blindTreatment
Summary
A Phase I, Randomized, Double-blinded, Placebo-Controlled First-in-human Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of J4 Dry Powder Capsule after Oral Administration of Single and Multiple Ascending Doses to Healthy Adults
Timeline
- Start
- 2025-02-14
- Primary completion
- 2026-12-31
- Completion
- 2026-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | J4 | Unknown | — | Oral |